Legacy Capital Group California Inc. Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Legacy Capital Group California Inc. increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 8.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 785 shares of the biotechnology company’s stock after acquiring an additional 61 shares during the period. Legacy Capital Group California Inc.’s holdings in Axon Enterprise were worth $467,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Asset Dedication LLC lifted its position in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC lifted its holdings in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after purchasing an additional 21 shares during the last quarter. Insigneo Advisory Services LLC grew its holdings in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC raised its position in shares of Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on AXON shares. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a report on Thursday. JMP Securities boosted their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. Finally, TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Trading Down 5.3 %

Shares of AXON stock opened at $513.22 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $265.32 and a fifty-two week high of $715.99. The company has a 50 day moving average price of $619.94 and a 200 day moving average price of $517.11. The stock has a market capitalization of $39.13 billion, a P/E ratio of 132.62, a price-to-earnings-growth ratio of 5.95 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock worth $5,631,561 over the last 90 days. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.